181 related articles for article (PubMed ID: 36303015)
21. Actinic lesions in fishermen's lower lip: clinical, cytopathological and histopathologic analysis.
Piñera-Marques K; Lorenço SV; Silva LF; Sotto MN; Carneiro PC
Clinics (Sao Paulo); 2010 Apr; 65(4):363-7. PubMed ID: 20454492
[TBL] [Abstract][Full Text] [Related]
22. Actinic cheilitis: histopathology and p53.
Neto Pimentel DR; Michalany N; Alchorne M; Abreu M; Borra RC; Weckx L
J Cutan Pathol; 2006 Aug; 33(8):539-44. PubMed ID: 16919027
[TBL] [Abstract][Full Text] [Related]
23. Relevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesis.
Gonçalves AS; Oliveira JP; Oliveira CF; Silva TA; Mendonça EF; Wastowski IJ; Batista AC
Hum Immunol; 2016 Sep; 77(9):785-90. PubMed ID: 26723902
[TBL] [Abstract][Full Text] [Related]
24. Correlation between cell cycle proteins and hMSH2 in actinic cheilitis and lip cancer.
Lopes ML; de Oliveira DH; Sarmento DJ; Queiroz LM; Miguel MC; da Silveira ÉJ
Arch Dermatol Res; 2016 Apr; 308(3):165-71. PubMed ID: 26842232
[TBL] [Abstract][Full Text] [Related]
25. Pattern of galectins expression in actinic cheilitis with different risks of malignant transformation.
Lopes ML; Nonaka CF; Queiroz LM; de Souza LB; Miguel MC; da Silveira ÉJ
J Oral Pathol Med; 2016 Sep; 45(8):621-6. PubMed ID: 26711374
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical comparative analysis of IMP-3 and KI-67 in actinic cheilitis and lower lip squamous cell carcinoma.
de Souza Martins Câmara AC; Gonzaga AKG; Dos Santos Pereira J; Queiroz SIML; da Silveira ÉJD; Pinto LP; de Souza LB
Oral Maxillofac Surg; 2022 Dec; 26(4):587-593. PubMed ID: 34817714
[TBL] [Abstract][Full Text] [Related]
27. Study of MDM2 and SUMO-1 expression in actinic cheilitis and lip cancer.
Oliveira Alves MG; da Mota Delgado A; Balducci I; Carvalho YR; Cavalcante AS; Almeida JD
Arch Dermatol Res; 2014 Nov; 306(9):837-41. PubMed ID: 25241153
[TBL] [Abstract][Full Text] [Related]
28. Actinic cheilitis: a premalignant condition.
Manganaro AM; Will MJ; Poulos E
Gen Dent; 1997; 45(5):492-4. PubMed ID: 9515418
[TBL] [Abstract][Full Text] [Related]
29. Daylight photodynamic therapy for the management of actinic cheilitis.
Andreadis D; Pavlou A-; Vakirlis E; Anagnostou E; Vrani F; Poulopoulos A; Kolokotronis A; Ioannidis D; Sotiriou E
Arch Dermatol Res; 2020 Dec; 312(10):731-737. PubMed ID: 32266532
[TBL] [Abstract][Full Text] [Related]
30. Erbium laser resurfacing for actinic cheilitis.
Cohen JL
J Drugs Dermatol; 2013 Nov; 12(11):1290-2. PubMed ID: 24196339
[TBL] [Abstract][Full Text] [Related]
31. Immune response and evasion mechanisms in lip carcinogenesis: An immunohistochemical study.
Lopes MLDS; Gonzaga AKG; Mosconi C; Palomino GM; Mendonça EF; Batista AC; Silveira ÉJDD
Arch Oral Biol; 2019 Feb; 98():99-107. PubMed ID: 30468994
[TBL] [Abstract][Full Text] [Related]
32. Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis.
de Oliveira DH; de Sousa Lopes ML; de Santana Sarmento DJ; Queiroz LM; da Costa Miguel MC; da Silveira EJ
J Oral Pathol Med; 2014 May; 43(5):357-63. PubMed ID: 24329813
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the association of myofibroblasts and structural components of the extracellular matrix with histopathological parameters of actinic cheilitis and lower lip squamous cell carcinoma.
Martinez FEO; Bezerra TMM; Alves APNN; Fernandes IJLS; Sousa FB; de Barros Silva PG; Mota MRL
J Oral Pathol Med; 2024 May; 53(5):321-330. PubMed ID: 38693618
[TBL] [Abstract][Full Text] [Related]
34. Immunoexpression of human leukocyte antigen-DR in actinic cheilitis and lower lip squamous cell carcinoma.
Sena LSB; Santos HBP; Amaral MGD; Gordón-Núñez MA; Alves PM; Nonaka CFW
Braz Oral Res; 2019 Aug; 33():e085. PubMed ID: 31483051
[TBL] [Abstract][Full Text] [Related]
35. Solar cheilosis: an ominous precursor: part I. Diagnostic insights.
Jadotte YT; Schwartz RA
J Am Acad Dermatol; 2012 Feb; 66(2):173-84; quiz 185-6. PubMed ID: 22243721
[TBL] [Abstract][Full Text] [Related]
36. Altered β-catenin expression related to cancer progression on actinic cheilitis and squamous cell carcinoma of the lip.
Schussel JL; Pinto Ddos S; Martins MT
Ann Diagn Pathol; 2011 Feb; 15(1):1-5. PubMed ID: 20970365
[TBL] [Abstract][Full Text] [Related]
37. Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.
Souza VG; Santos DJS; Silva AG; Ribeiro RIMA; Loyola AM; Cardoso SV; Miranda CSS; Cardoso LPV
J Appl Oral Sci; 2022; 30():e20210344. PubMed ID: 35195152
[TBL] [Abstract][Full Text] [Related]
38. The relevance of miRNAs as promising biomarkers in lip cancer.
Assao A; Domingues MAC; Minicucci EM; Marchi FA; Coutinho-Camillo CM; Oliveira DT
Clin Oral Investig; 2021 Jul; 25(7):4591-4598. PubMed ID: 33439343
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of specific modified histones in lip carcinogenesis.
de Freitas Filho SAJ; Servato JPS; de Sá RT; Siqueira CS; de Faria PR; Loyola AM; Cardoso SV
Pathol Res Pract; 2018 Jun; 214(6):876-880. PubMed ID: 29699903
[TBL] [Abstract][Full Text] [Related]
40. Possible role of ALDH1 and CD44 in lip carcinogenesis.
Ortiz RC; Gois GG; Costa CA; Costa NL; Rodini CO
J Appl Oral Sci; 2023; 31():e20230227. PubMed ID: 38126564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
